Abstracts Archive - Page 1215 of 2425 - ACR Meeting Abstracts

Abstract Number: 141 • 2017 ACR/ARHP Annual Meeting
Refractory Disease in Rheumatoid Arthritis: Results from the British Society of Rheumatology Biologics Register for Rheumatoid Arthritis
Lianne Kearsley-Fleet¹, Diederik De Cock¹, Kath Watson¹, Maya H. Buch², John D Isaacs³ and Kimme L. Hyrich^1,4, ¹Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom, ²Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, ³National Institute for Health Research Newcastle Biomedical Research Centre, Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle, United Kingdom, ⁴National Institute of Health Research Manchester Musculoskeletal Biomedical Research Centre, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
Background/Purpose: Biologic therapy has revolutionised treatment pathways and improved outcomes for patients with Rheumatoid Arthritis (RA) who do not tolerate or respond to conventional synthetic…
Abstract Number: 142 • 2017 ACR/ARHP Annual Meeting
Incidence of Hip Fracture in Rheumatoid Arthritis: British Columbia, Canada
C. Allyson Jones¹, Pierre Guy², Hui Xie³, Eric C. Sayre⁴ and Diane Lacaille^5,6, ¹Physical Therapy, University of Alberta, Edmonton, AB, Canada, ²Department of Orthopaedics, University of British Columbia / Centre for Hip Health and Mobility, Vancouver, BC, Canada, ³Biostatistics, Faculty of Health Sciences, Simon Fraser University / Arthritis Research Canada, Burnaby, BC, Canada, ⁴Arthritis Research Canada, Richmond, BC, Canada, ⁵Arthritis Research Canada/ University of British Columbia, Vancouver, BC, Canada, ⁶University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada
Background/Purpose: Hip fractures have serious long-term effects, including a high 1-year mortality rate (usually 20-30%) and poor functional recovery, with approximately 50% not attaining pre-fracture…
Abstract Number: 143 • 2017 ACR/ARHP Annual Meeting
Patient Rheumatoid Arthritis Data from the Real World (PARADE) Study: Preliminary Results from an Apple Researchkit™ Mobile App-Based Real World Study in the United States
Rachel Williams¹, Emilia Quattrocchi², Sarah Watts³, Sherry Wang⁴, Pam Berry⁴ and Michelle Crouthamel⁴, ¹Real World Evidence and Epidemiology, GSK, Collegeville, PA, ²R&D Immunoinflammation, GSK, Middlesex, United Kingdom, ³GSK, Stevenage, United Kingdom, ⁴GSK, Collegeville, PA
Background/Purpose: Smartphone apps and sensors enable researchers to design novel endpoints and collect real world data directly from patients in a cost-effective, fast, and patient-focused…
Abstract Number: 144 • 2017 ACR/ARHP Annual Meeting
Are RA Patients at a Higher Risk for Car Accidents?
Kaleb Michaud^1,2, Sofia Pedro¹ and Ted R. Mikuls³, ¹National Data Bank for Rheumatic Diseases, Wichita, KS, ²University of Nebraska Medical Center, Omaha, NE, ³Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE
Background/Purpose: Automobile driving is an important instrumental activity of daily living with heightened importance among arthritis sufferers who are disproportionately reliant on driving for the…
Abstract Number: 145 • 2017 ACR/ARHP Annual Meeting
Cause-Specific Mortality in a Large Population-Based Cohort of Rheumatoid Arthritis Patients in Italy
Francesca Ometto¹, UGO FEDELI², ELENA SCHIEVANO², Costantino Botsios³, MARIA CHIARA CORTI² and Leonardo Punzi⁴, ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova, PADOVA, Italy, ²Epidemiological Department, Veneto Region, VENETO, Italy, ³Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy, ⁴Rheumatology Unit, Department of Medicine DIMED, University of Padova, Padova, Italy
Background/Purpose: Studies on mortality in RA from Italy are completely lacking. The aim of our study was to investigate cause-specific mortality in RA subjects living…
Abstract Number: 146 • 2017 ACR/ARHP Annual Meeting
Major Cardiovascular Events Among an Inception Cohort of Seniors with Rheumatoid Arthritis
Jessica Widdifield^1,2, Michael Paterson², Anjie Huang², Bindee Kuriya³, Carter Thorne⁴, Janet E. Pope⁵ and Sasha Bernatsky⁶, ¹Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, ON, Canada, ²Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ³Sinai Health System, University of Toronto, Toronto, ON, Canada, ⁴Southlake Regional Health Centre, Newmarket, ON, Canada, ⁵Department of Medicine, Division of Rheumatology, University of Western Ontario, St Joseph's Health Care, London, ON, Canada, ⁶Division of Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: We previously observed that incident RA patients have an increased risk of cardiovascular (CV) mortality relative to the general population in Ontario. Our aim…
Abstract Number: 147 • 2017 ACR/ARHP Annual Meeting
Performance of Cardiovascular Risk Age and Vascular Age Estimations in Predicting Cardiovascular Events in Rheumatoid Arthritis
Grunde Wibetoe¹, Cynthia S. Crowson², Joseph Sexton³, Silvia Rollefstad¹, Eirik Ikdahl¹, George D. Kitas⁴, Piet van Riel⁵, Sherine E. Gabriel⁶, Tore K. Kvien⁷, Karen Douglas⁸, Aamer Sandoo^8,9, Elke Arts⁵, Solveig Wållberg-Jonsson¹⁰, Solbritt Rantapää Dahlqvist¹⁰, George Karpouzas¹¹, Patrick H. Dessein^12,13, Linda Tsang¹⁴, Hani El-Gabalawy¹⁵, Carol A Hitchon¹⁵, Virginia Pascual-Ramos¹⁶, Irazu Contreras-Yañez¹⁷, Petros P Sfikakis¹⁸, Evangelia Zampeli¹⁹, Miguel Angel González-Gay²⁰, Alfonso Corrales²¹, Iris J. Colunga-Pedraza²², Dionicio A. Galarza-Delgado²³, Jose Ramon Azpiri-Lopez²⁴ and Anne Grete Semb¹, ¹Preventive Cardio-Rheuma clinic, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ²Department of Medicine, Division of Rheumatology,Mayo Clinic, Rochester, MN, ³Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, ⁴School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, ⁵Department of Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ⁶Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, ⁷NORDMARD, Oslo, Norway, Oslo, Norway, ⁸Dudley Group NHS Foundation Trust, West Midlands, United Kingdom, ⁹School of Sport, Health and Exercise Sciences, Bangor University, Bangor, United Kingdom, ¹⁰University of Umeå, Umeå, Sweden, ¹¹Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, ¹²Vrije Universiteit Brussel, Brussel, Belgium, ¹³Universitair Ziekenhuis Brussel, Brussel, Belgium, ¹⁴Rheumatology, Universitair Ziekenhuis Brussel, Brussels, Belgium, ¹⁵University of Manitoba, Winnipeg, MB, Canada, ¹⁶Instituto Nacional de Ciencias Médicas y Nutrició, Mexico City, Mexico, ¹⁷Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, ¹⁸First Department of Propedeutic Internal Medicine, Laikon Hospital, Athens University Medical School, Athens, Greece, ¹⁹Institute of Autoimmune Systemic and Neurological Diseases, National and Kapodistrian University of Athens, Athens, Greece, ²⁰Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Johannesburg, South Africa, ²¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²²Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ²³Chief of Rheumatology, Hospital Universitario, UANL., Monterrey, Mexico, ²⁴Cardiology, Hospital Universitario, UANL., Monterrey, Mexico
Background/Purpose: Rheumatoid arthritis (RA) patients are at high risk of cardiovascular disease (CVD). Risk algorithms for the general population lack precision when applied to RA…
Abstract Number: 148 • 2017 ACR/ARHP Annual Meeting
Lack of Screening By Rheumatologists and Primary Care Physicians for Childhood Sexual Abuse in Patients with Fibromyalgia-Depression Overlap: An Unrecognized Crisis?
M. Anthony Albornoz¹, Christian Albornoz² and Daniel J. Clauw³, ¹Rheumatology, Riddle Memorial Hospital/Mainline Health System, Media, PA, ²Temple University School of Medicine, Philadelphia, PA, ³Chronic Pain & Fatigue Research Center, University of Michigan, Ann Arbor, MI
Background/Purpose: Depression is reported in as many as 71% of patients with Fibromyalgia (FM). An association between Childhood Sexual Abuse (CSA) and FM has been…
Abstract Number: 149 • 2017 ACR/ARHP Annual Meeting
Effect of Vitamin D Supplementation in Chronic Widespread Pain: A Systematic Review and Meta-Analysis
Wai Chung Yong, Anawin Sanguankeo and Sikarin Upala, Bassett Medical Center, Cooperstown, NY
AbstractBackground/Purpose: Chronic non-specific widespread pain (CWP) including fibromyalgia (FM) is characterized by widespread pain, reduced pain threshold and multiple tender points on examination, causing disability…
Abstract Number: 150 • 2017 ACR/ARHP Annual Meeting
Effects of Taping Therapy in the Management of Fibromyalgia: A Randomized Controlled Study
Hae Joo Suh¹ and Sang Tae Choi², ¹Seoul National University Hospital, Seoul, Korea, Republic of (South), ²Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea, Republic of (South)
Background/Purpose: Fibromyalgia is a medical condition characterized by chronic widespread musculoskeletal pain, accompanied by fatigue, insomnia, cognitive problems, psychiatric symptoms and various somatic symptoms. While…
Abstract Number: 151 • 2017 ACR/ARHP Annual Meeting
Prevalence of Fibromyalgia in Nurses; A Cross Sectional Study
Sarah Alajmi¹, Faisal Shahwan¹, Yazeed Bajuaifer¹, Rand Al Ohaly², Maha Edrees², Alanood Asiri² and Mohammed Omair³, ¹Internal Medicine, King Saud University Medical City, Riyadh, Saudi Arabia, ²King Saud University Medical City, Riyadh, Saudi Arabia, ³Division of Rheumatology, Department of Medicine, King Saud University, Riyadh, Saudi Arabia
Background/Purpose: Nurses are at increased of developing pain sensitization syndromes due to stress and interrupted sleep. The prevalence of fibromyalgia (FM) in nurses is unknown.…
Abstract Number: 152 • 2017 ACR/ARHP Annual Meeting
Patients Failing to Fulfill 2016 Criteria for Fibromyalgia Represent a Truly Different Population Subset
Marco Antivalle^1,2, Maria Chiara Ditto³, Alberto Batticciotto³, Rossella Talotta³, Maria Chiara Gerardi³, Alessandra Mutti³, Fabiola Atzeni³ and Piercarlo Sarzi-Puttini³, ¹Rheumatology, Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, ²Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy, ³Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy
Background/Purpose: The 2010/2011 fibromyalgia (FMS) diagnostic criteria (1) were recently revised, with the addition of a generalized pain criterion in order to avoid misclassification of…
Abstract Number: 153 • 2017 ACR/ARHP Annual Meeting
Prevalence of Fibromyalgia in Physician in Training; A Cross Sectional Study
Sarah Alobud¹, Nour Alsultan¹, Abeer Alhazzani¹, Yasmin Altymani¹, Muneera Albugami¹, Maha Omair² and Mohammed Omair³, ¹King Saud University, Riyadh, Saudi Arabia, ²Department of Statistics, College of Science, King Saud University, Riyadh, Saudi Arabia, ³Division of Rheumatology, Department of Medicine, King Saud University, Riyadh, Saudi Arabia
Background/Purpose: Physicians in training (PIT) are at increased of developing pain sensitization syndromes due to stress and interrupted sleep. The prevalence of fibromyalgia (FM) in…
Abstract Number: 154 • 2017 ACR/ARHP Annual Meeting
Frequency of Fibromyalgia in Patients with Antiphospholipid Syndrome. a Cross-Sectional Study
Nicole Mouneu Ornelas¹, Laura-Aline Martinez-Martinez², Vijaya Rivera³, Ricardo Alberto Venegas Yañez⁴, Victor Alejandro Escamilla Gomez⁵, Gumaro Acosta Peña⁶, Luis H. Silveira⁷, Angelica Vargas Guerrero³, Luis M. Amezcua-Guerra³ and Manuel Martínez-Lavín³, ¹Internal Medicine, Instituto Nacional de Cardiología - Ignacio Chávez, IGNACIO CHÁVEZ, Mexico, ²Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, TX, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, ⁴Reumatologia, Instituto Nacional de Cardiología "Ignacio Chavez", Ciudad de México, Mexico, ⁵Rheumatology, Instituto Nacional de Cardiología - Ignacio Chávez, Mexico City, Mexico, ⁶Instituto Nacional de Cardiología, Ciudad de mexico, Mexico, ⁷Rheumatology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City DF, Mexico
Background/Purpose: The observation of several cases with coexistent antiphospholipid syndrome (APS) and fibromyalgia led us to this investigation. The objective was to define the frequency…
Abstract Number: 155 • 2017 ACR/ARHP Annual Meeting
Xerostomia in Patients with Fibromyalgia
Nicolas Lloves¹, Anastasia Secco², Virginia Durigan³, Santiago Scarafia², Felix Romanini Sr.⁴ and Marta Mamani⁴, ¹Rheumatology Department, Hospital Rivadavia, Buenos Aires, Argentina, ²Hospital Bernardino Rivadavia, CABA, Argentina, ³Reumatology, Hospital Bernardino Rivadavia, CABA, Argentina, ⁴Hospital Rivadavia, Buenos Aires, Argentina
Background/Purpose: Fibromyalgia (FM) is a rheumatic disease characterized by diffuse, chronic musculoskeletal pain, of non-articular origin, which is evidenced by the palpation of painful points…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].